Announcements
- Teleflex Publishes 2023 Global Impact Report
- Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray
- Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
- Teleflex Announces Quarterly Dividend
- Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
- Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
- Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire
- Teleflex to Present at the BofA Securities 2024 Health Care Conference
- Teleflex Announces First Quarter 2024 Earnings Conference Call Information
- Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
More ▼
Key statistics
On Friday, TELEFLEX INCDRN (T1FX34:SAO) closed at 109.30, 9.55% above its 52-week low of 99.77, set on Nov 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | 109.12 |
Offer | 110.00 |
Previous close | 109.30 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.5254 BRL |
---|---|
Annual div yield (ADY) | 0.48% |
Div ex-date | May 14 2024 |
Div pay-date | Jun 20 2024 |
Data delayed at least 15 minutes, as of May 31 2024 20:49 BST.
More ▼